From artists reclaiming abandoned alleys to centuries‑old harbors splashed in fresh paint, these rainbow‑hued passages reveal how communities celebrate history, identity, and sheer creativity. Each ...

The FDA has approved a dihydroergotamine-based nasal powder for the acute treatment of migraine with or without aura in ...

Atzumi was previously known as STS101. The company noted that Atzumi is not indicated for the preventive treatment of migraine or for the management of hemiplegic migraine or migraine with ...

But if there is a frequent headache, then we should not take it lightly because these can be symptoms of migraine. Migraine problems can cause trouble in people's daily work. Migraine pain ...

Certain vitamins, minerals, herbs, and nutrients may offer health benefits for people with migraine. You can get them through food or supplements. The term “migraine” refers to a recurring ...

More than a year after it was rejected by the FDA, Satsuma Pharma's intranasal migraine therapy Atzumi (formerly STS101) has been given the go-ahead by the agency. The drug – a new dry powder ...

For years, Laura could count on having debilitating migraine attacks a handful of times per month without fail. Their frequency would increase during months when she was especially stressed or ...

The recommended dose of Atzumi is 5.2mg, the contents of 1 nasal device, administered into 1 nostril. The Food and Drug Administration (FDA) has approved Atzumi ™ (dihydroergotamine) nasal ...

However, for some, the onset of summer can bring about less desirable effects such as swollen ankles, dehydration, or migraines. A migraine is typically described as an intense headache ...

The FDA approved dihydroergotamine (DHE) nasal powder (Atzumi) 5.2 mg to treat acute migraine with or without aura in adults, ...